Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
B

Preliminary Results of Phase II Trial of Brentuximab Vedotin and Lenalidomide in Relapsed / Refractory Cutaneous / Peripheral T-Cell Lymphomas

By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Basem William
By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Basem William
31 views
October 18, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal
T-cell Lymphoma
15:48

New Frontline Regimens in Peripheral T-Cell Lymphoma: Brentuximab Ve…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

J. Vose

187 views
16:59

Novel Approaches in Peripheral T-Cell Lymphoma Treatment: Challenges…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

O. O’Connor

38 views
09:35

New Insights into the Molecular Pathogenesis of Peripheral T-Cell Ly…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

P. Gaulard

32 views
07:09

Preliminary Results of Phase II Trial of Brentuximab Vedotin and Len…

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

B. William

31 views